RecruitingNot ApplicableNCT05758805

Esophageal Injury of a Tip CF Sensing Ablation Catheter for HP-SD of Paroxysmal and Persistent AF (ESO-SAFE-HP-RF)

Esophageal Injury of a Tip CF Sensing Ablation Catheter for HP-SD of Paroxysmal and Persistent AF


Sponsor

Quovadis Associazione

Enrollment

51 participants

Start Date

Jan 8, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This pilot, prospective, interventional, monocentric, independent, and no-profit clinical trial aims to investigate and evaluate the proportion, acute and chronic characteristics, and outcomes of esophageal thermal injury (ETI) in AF ablation using a high-power, short-duration (HP-SD) setting with contact force (CF) sensing tip ablation catheter in standard clinical practice. The main questions it aims to answer are: * Evaluate the acute proportion of the ETI assessed by the mini-invasive esophagoscopy pre and post-procedure. In addition, clinical evaluations at 3, 6, and 12 months from the procedure are foreseen. * Evaluate the contribution of the factors influencing RF procedure (contact force, impedance, RF power, RF time) on ETI development. * Describe the relationship between the esophageal temperature (continuous monitoring) and ETI development.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria2

  • Atrial fibrillation and, according to current guidelines, indication for radiofrequency ablation guided by electro-anatomical mapping with high-density mapping catheter and radiofrequency ablation by contact force ablation catheter.
  • Able to sign the consent form.

Exclusion Criteria15

  • LVEF \< 45%
  • Presence of thrombus in the left atrium
  • NYHA III/IV Class
  • Atrial diameter \> 50mm
  • Moderate or severe valve dysfunction
  • Implanted ICD/CRT-D
  • Life expectancy \< 1 year
  • Uncontrolled Hyperthyroidism
  • Hypertrophic or dilatative cardiomyopathy
  • Kidney failure (eGFR \< 30)
  • Body Mass Index (BMI)\> or = 35
  • Participation in another clinical trial in the past 3 months
  • Inability to express informed consent for the study
  • Patients with esophageal pathologies and a history of gastritis
  • Pregnancy (ascertained by performing the HCG test), breastfeeding, pregnancy planned during the study, or fertile female subjects who refused to use a highly effective contraceptive measure.

Interventions

DEVICEmini-invasive esophagoscopy

mini-invasive esophagoscopy assessment of esophageal thermal injury (ETI) after an AF ablation session in an HP-SD setting, and with a tip CF sensing ablation catheter

DEVICEHP-SD AF ablation by a CF sensing catheter

AF ablation session in an HP-SD setting and with a tip CF sensing ablation catheter


Locations(1)

SOD di Cardiologia e Aritmologia

Ancona, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05758805


Related Trials